TABLE 2.
Characteristic | Total (N = 35 Hospitals) | Sedation Cluster 1 (Opioid and Propofol Predominant; n = 27 Hospitals)a | Sedation Cluster 2 (Opioid and Benzodiazepine Predominant; n = 8 Hospitals)a |
---|---|---|---|
| |||
Geographic site | |||
United States | 25 (71) | 21 (78) | 4 (50) |
International | 10 (29) | 6 (22) | 4 (50) |
Lack of hospital resources during hospitalization | 9 (26) | 4 (50) | 5 (19) |
ICU typeb | |||
Medical ICU | 9 (38) | 9 (41) | 0 (0) |
Mixed medical-surgical ICU | 7 (29) | 6 (27) | 1 (50) |
Dedicated COVID-19 ICU | 8 (33) | 7 (32) | 1 (50) |
ICU nurse to patient ratiob | |||
1:1 | 2 (8) | 2 (9) | 0 (0) |
1:2 | 20 (83) | 18 (82) | 2 (100) |
1: > 2 | 1 (4) | 1 (5) | 0 (0) |
Other | 1 (4) | 1 (5) | 0 (0) |
Total ICU bedsb | 25 (16–36) | 24 (16–36) | 40 (30–50) |
Trainees (residents or fellows) present in the ICUb | 17 (71) | 15 (68) | 2 (100) |
Data are presented as No. (%) or median (interquartile range). Percentages do not all sum to 100% because of rounding.
See Table 3 for full description of analgesia and sedation practices within clusters.
Missing for 31% of hospitals (28% of patients).